Just read about a phase 3 Melanoma treatment study today, a “Takeover Target”. I’m not a subscriber to Takeover Targets. He says this company is likely a takeover target by Astra Zeneca, and they are already partnered with Astra Zeneca. It’s a therapy which makes a treatment out of your own tumor. I have a very good friend who had stage IV melanoma and took part in a study many years ago that used this type of treatment and it seemed to work. Don’t know how this differs, does anyone know the company he is talking about?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.